These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 29358129

  • 1. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
    Song XL, Huang B, Zhou BW, Wang C, Liao ZW, Yu Y, Zhao SC.
    Biomed Pharmacother; 2018 Mar; 99():369-374. PubMed ID: 29358129
    [Abstract] [Full Text] [Related]

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
    Guan H, Liu C, Fang F, Huang Y, Tao T, Ling Z, You Z, Han X, Chen S, Xu B, Chen M.
    Oncotarget; 2017 Feb 28; 8(9):14693-14707. PubMed ID: 28107193
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B, He BX, Cai JH, Tao Q, King-Yin Lam A.
    Sci Rep; 2017 Apr 20; 7():44688. PubMed ID: 28425477
    [Abstract] [Full Text] [Related]

  • 5. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
    Yang HW, Liu GH, Liu YQ, Zhao HC, Yang Z, Zhao CL, Zhang XF, Ye H.
    Biomed Pharmacother; 2016 Oct 20; 83():593-601. PubMed ID: 27459115
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-1254 promotes lung cancer cell proliferation by targeting SFRP1.
    Li H, Yang T, Shang D, Sun Z.
    Biomed Pharmacother; 2017 Aug 20; 92():913-918. PubMed ID: 28605875
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
    Feng ZY, Xu XH, Cen DZ, Luo CY, Wu SB.
    Eur Rev Med Pharmacol Sci; 2017 Nov 20; 21(21):4844-4852. PubMed ID: 29164578
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter C, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG.
    Oncotarget; 2016 Aug 30; 7(35):56628-56642. PubMed ID: 27447749
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X, Fu Z.
    J Transl Med; 2017 Dec 19; 15(1):257. PubMed ID: 29258530
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L, Chen H, Song J, Chen X, Lin C, Zhang X, Hou N, Pan J, Zhou Z, Wang L, Huang D, Yang J, Liang Y, Li J, Huang H, Jiang L.
    Theranostics; 2019 Dec 19; 9(2):449-465. PubMed ID: 30809286
    [Abstract] [Full Text] [Related]

  • 20. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D, Lu G, Shao Y, Xu D.
    Biomed Pharmacother; 2018 Mar 19; 99():334-339. PubMed ID: 29353209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.